Examine the stock returns for both Pfizer and AstraZeneca during the Essay

Examine the stock returns for both Pfizer and AstraZeneca during the bid work and provide possible reasons for changes in price on key dates - Essay Example7.36). Comparing by the revenues, Pfizer is a larger company than AstraZeneca both the companies being products of the merger.Pfizer made four approaches earlier in 2014 terminating the bids in a full and final offer of 55 sterling pounds per share valuing AstraZeneca at 69 one million million million pounds (Battersby & Grimes 2014, p. 7.37). The current debt to equity proportion at Pfizer is at 0.49, a low and a below bonny industrial average. The low figure is an indication of good management of debt levels within the firm. Pfizer had a quick ratio of 2.03 demonstrating their capability to cover and settle short time liquidity needs.The gross profit of Pfizer during the bidding sour span was a high figure of 85.18 percentage with its network profit margin accounted at 22.92 percent. The net operating cash flow had a sligh t increase to $4,087 million, a figure equivalent to 6.71 percent comparable to the same quarter one year ago (US. Pharmaceuticals & Healthcare Report 2014, P.15).AstraZeneca rejected Pfizers final offer on grounds that the takeover may pose a risk to its pharmaceutic operations. In addition, the fear of the uncertainty that could arise led to the collapse of the bid process. It became hard for AstraZeneca to evaluate Pfizers final bid given the uncertainty over the total standard that Pfizer could trim off its tax income bill by venturing in Britain.Pfizer offered a final bid of 69.4 billion sterling pounds, an equivalent amount to $ 117 billion terming the figures full and final. Lack of a proven parameter for evaluating a company with a outgrowth and attractive growth prospects led to changes in prices on the final day. Pfizer failed to factor in AstraZenecas future tense prospects in terms of sales and market base.The concerns on whether Pfizer would eliminate jobs after the merger and diminish Britains standing in life sciences indicate the political influence